TriNet Group, Inc. — Q3 2022 Form 10-Q
Reporting period: Three and nine months ended September 30, 2022. Amounts below are in U.S. dollars; financial figures are in millions except per-share data and operating metrics. TriNet provides HR, payroll, benefits, insurance and related services to SMBs, primarily through its PEO model, and added cloud HCM and R&D tax-credit services through acquisitions.
Financial and operating performance
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Total revenue | $1,241 | $1,148 | $3,659 | $3,308 |
| Operating income | $120 | $105 | $443 | $364 |
| Net income | $77 | $77 | $307 | $269 |
| Diluted EPS | $1.22 | $1.16 | $4.81 | $4.03 |
| Adjusted EBITDA (non-GAAP) | $173 | $132 | $577 | $449 |
| Adjusted net income (non-GAAP) | $104 | $87 | $378 | $302 |
| Insurance cost ratio | 83% | 86% | 82% | 84% |
| Average worksite employees | 351,888 | 347,502 | 348,833 | 333,839 |
Q3 revenue rose 8%, while operating income increased 14%; net income was flat. For the first nine months, revenue rose 11%, operating income 22%, and net income 14%. Revenue growth reflected rate increases, higher average WSEs, Zenefits HCM revenue and, in Q3, Clarus R&D. Q3 average WSEs increased 1% year over year, with growth in Technology and Life Sciences partly offset by slower hiring and attrition in other verticals.
Insurance costs were $872 in Q3 and $2,547 year to date. The lower comparative insurance cost ratio reflected revenue growth and favorable prior-year workers’ compensation claim development; management also reported higher medical utilization and COVID-related costs. Operating expenses increased 30% in Q3 and 23% year to date, including higher compensation, technology and consulting costs, acquisition-related expenses, and investments in client experience and services.
Cash, liquidity and debt
For the first nine months, operating cash flow was $76, versus cash used of $16 in the prior-year period. Corporate operating cash flow, a non-GAAP measure, was $436 versus $334; WSE-related operating cash flow was negative $360, largely reflecting timing and settlement activity. Investing cash outflow was $205, including $219 of net cash used for acquisitions and $39 of capital expenditures. Financing cash outflow was $392, primarily reflecting share repurchases.
At September 30, 2022, corporate working capital was $444, down from $700 at year-end 2021. The balance sheet reported $454 of unrestricted cash and cash equivalents, $95 of current investments, $237 of unrestricted investments in total, and $837 of current restricted cash, cash equivalents and investments. Restricted funds include client payroll prefunding and insurance collateral and are not equivalent to freely available corporate cash. Total assets were $3,079 and stockholders’ equity was $856.
Long-term debt was reported at $496; $500 principal amount of 3.50% senior notes due 2029 was outstanding. The $500 revolving credit facility had $495 available, and TriNet reported compliance with its financial covenants. Management stated existing liquidity and expected operating cash flows should meet reasonably foreseeable needs for at least 12 months.
Material changes, outlook and risks
- TriNet acquired Zenefits in February for a reported purchase price of $209 and Clarus R&D in September for $48. Acquired goodwill and intangible assets, and ongoing integration, are relevant to future results; purchase-price allocations remained preliminary.
- A $25 reduction to insurance service revenue was recognized in Q2 for the 2022 Credit Program. The estimated client credits are payable within 12 months and may be reduced if health costs are higher than expected.
- TriNet repurchased 4.4 million shares for approximately $380, plus costs, during the first nine months. Approximately $184 remained authorized for repurchases at quarter end.
- Interest expense, bank fees and other included $11 of realized investment-sale losses and $7 of non-credit impairment losses, associated with the possibility of further sales. These losses contributed to higher other expense.
- No specific numerical earnings or revenue guidance is provided in the supplied filing text. Management describes continued investment in client experience, technology, service offerings and process improvements, and expects ongoing software and hardware capital investment.
- Principal risks discussed include variable health and workers’ compensation claim frequency and severity, medical-cost trends, client attrition and SMB economic conditions, regulatory and co-employment exposure, cyber and technology risks, and acquisition integration. Management said risk factors had not materially changed from its 2021 Form 10-K.
- A retirement-plan ERISA case had a class certified for claims concerning the TriNet Select 401(k) Plan, while class certification was declined for claims concerning the TriNet 401(k) Plan. TriNet said it could not reasonably estimate a possible loss and considered the claims without merit.
- The company reported effective disclosure controls. It also noted that substantial ERP implementation during Q2 changed certain financial-reporting processes and controls.
Key facts for investors to verify
- Whether medical utilization, insurance claims and the insurance cost ratio remain consistent with pricing assumptions, and how prior-year favorable claim development evolves.
- The eventual cost and payment of the 2022 Credit Program, including any change to the $25 estimate.
- Acquisition integration, revenue contribution and final purchase accounting for Zenefits and Clarus R&D, including goodwill and intangible-asset assumptions.
- Corporate liquidity available after distinguishing unrestricted assets from WSE payroll funds and insurance collateral; also monitor cash flow timing and share repurchases.
- Developments in the 401(k) litigation and any change in the company’s ability to estimate potential exposure.